National Institute on Alcohol Abuse and Alcoholism; Amended Notice of Meeting, 15483 [2020-05645]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 53 / Wednesday, March 18, 2020 / Notices
Health, 5601 Fishers Lane, Room 3G22,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Inka I Sastalla, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G22, Rockville, MD
20852, (301) 761–6431, inka.sastalla@
nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS–NIH–CDC SBIR PHS
2018–1 Phase II Topic 052: High-Throughput
Assay Platform for Quantifying Latent HIV
Reservoirs.
Date: April 21, 2020.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G22,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Inka I Sastalla, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G22, Rockville, MD
20852, (301) 761–6431, inka.sastalla@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 13, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
National Institute of Allergy and
Infectious Diseases: Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
18:54 Mar 17, 2020
Jkt 250001
Dated: March 12, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–05627 Filed 3–17–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, March
26, 2020, 8:00 a.m. to March 27, 2020,
7:00 p.m., Marriott Bethesda North
Hotel & Conference Hotel, 5701
Marinelli Rd., Rockville, MD 20850
which was published in the Federal
Register on January 30, 2020, 85 FR
5459.
This meeting notice is amended to
change the meeting location, times, and
format. The meeting will now be held
on March 26, 2020, 8:00 a.m. to March
27, 2020, 4:00 p.m. as a teleconference
at National Cancer Institute (NCI) Shady
Grove, 9609 Medical Center Drive,
Rockville, MD 20850. The meeting is
closed to the public.
Dated: March 13, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–05641 Filed 3–17–20; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Amended Notice of
Meeting
[FR Doc. 2020–05630 Filed 3–17–20; 8:45 am]
VerDate Sep<11>2014
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Planning Grant (R34 Clinical Trial Not
Allowed).
Date: April 21, 2020.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G53
Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Konrad Krzewski, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G53, Rockville, MD
20852, 240–747–7526, konrad.krzewski@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
15483
Notice is hereby given of a change in
the meeting of the National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, April 24, 2020, 8:00
a.m. to 5:00 p.m., National Institutes of
Health, National Institute on Alcohol
Abuse and Alcoholism, 6700B
Rockledge Drive, Bethesda, MD 20817,
which was published in the Federal
Register on January 27, 2020, 85 FR
4673.
This meeting notice is amended to
change the meeting dates, times, and
format. The meeting will now be held as
a teleconference on two days—April 23,
2020, 8:00 a.m. to April 24, 2020, 6:00
p.m. The meeting is closed to the
public.
Dated: March 13, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–05645 Filed 3–17–20; 8:45 am]
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Heart, Lung,
and Blood Institute Special Emphasis
Panel, March 24, 2020, 08:00 a.m. to
05:00 p.m., Embassy Suites at Chevy
Chase Pavilion, 4300 Military Road NW,
Washington, DC 20015 which was
published in the Federal Register on
January 29, 2020, 85 FR 5221.
The NHLBI Special Emphasis Panel
meeting is being amended due to a
change in the meeting format. This oneday meeting to be held on March 24,
2020 will be a teleconference meeting.
The meeting is closed to the public.
Dated: March 13, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–05625 Filed 3–17–20; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
PO 00000
Frm 00071
Fmt 4703
Sfmt 9990
E:\FR\FM\18MRN1.SGM
18MRN1
]]>Agencies
[Federal Register Volume 85, Number 53 (Wednesday, March 18, 2020)]
[Notices]
[Page 15483]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05645]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel, April
24, 2020, 8:00 a.m. to 5:00 p.m., National Institutes of Health,
National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge
Drive, Bethesda, MD 20817, which was published in the Federal Register
on January 27, 2020, 85 FR 4673.
This meeting notice is amended to change the meeting dates, times,
and format. The meeting will now be held as a teleconference on two
days--April 23, 2020, 8:00 a.m. to April 24, 2020, 6:00 p.m. The
meeting is closed to the public.
Dated: March 13, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-05645 Filed 3-17-20; 8:45 am]
BILLING CODE 4140-01-P
